Stealth BioTherapeutics (MITO) Tops Q3 EPS by 1c; Reports Cash and Cash Equivalents of $42.3M

Stealth BioTherapeutics (NASDAQ: MITO) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02).

For earnings history and earnings-related data on Stealth BioTherapeutics (MITO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c